SCHEMBL18199797

SCHEMBL18199797

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c(c4)Oc4cc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)ccc4S5)ccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ ATM Q13315 1/20 0.49
▸ EDNRA P25101 6/20 0.36
▸ EDNRB P24530 2/20 0.36
▸ PTGER4 P35408 1/20 0.34
▸ KMT2A Q03164 4/20 0.33
▸ TSPO P30536 1/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ TSHR P16473 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ POLB P06746 1/20 0.32
▸ BRCA1 P38398 1/20 0.32
▸ HPGD P15428 1/20 0.31
▸ MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18199816 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMEDNRAEDNRB
SCHEMBL18622759 0.85 L3MBTL1 (0.53) L3MBTL1KDM4EATMEDNRAEDNRB
SCHEMBL18199805 0.83 KDM4E (0.42) L3MBTL1KDM4EATMEDNRAEDNRB
SCHEMBL11981026 0.82 L3MBTL1 (0.72) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL29431010 0.82 L3MBTL1 (0.72) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL29354385 0.82 L3MBTL1 (0.72) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL5999723 0.82 L3MBTL1 (0.72) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL11981068 0.82 L3MBTL1 (0.72) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL14900748 0.82 L3MBTL1 (0.72) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL29387946 0.82 L3MBTL1 (0.72) L3MBTL1KDM4EATMPTGER4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9634260-B2 Method for preparing conjugated compound having phenoxathiin and electron donating group of conjugated aromatic unit, and OLED device having the conjugated compound SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2017-04-25 — — US disclosed
US-9634260-B2 Method for preparing conjugated compound having phenoxathiin and electron donating group of conjugated aromatic unit, and OLED device having the conjugated compound SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2017-04-25 — — US disclosed
US-20160322584-A1 CONJUGATED COMPOUND HAVING PHENOXATHIINL, METHOD FOR PREPARING THE SAME AND OLED DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2016-11-03 — — US disclosed
US-20160322584-A1 CONJUGATED COMPOUND HAVING PHENOXATHIINL, METHOD FOR PREPARING THE SAME AND OLED DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2016-11-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160322584-A1 CONJUGATED COMPOUND HAVING PHENOXATHIINL, METHOD FOR PREPARING THE SAME AND OLED DEVICE AOC2, OCIAD2, AOX1 L3MBTL1 3788/4885KDM4E 3510/4885ATM 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback